Nipro Corporation
[Nipro] Subsidiary Sale and Business Restructuring | June 2026
Nipro resolved at its Board of Directors meeting on June 26, 2026, to transfer shares of the subsidiaries Gentuity and the equity-method affiliate Spryte, implementing a business restructuring. There will be no impact on consolidated performance, with transfer amounts approximately 21.3 billion yen and 5 billion yen respectively.
Key Figures
- Transfer amount (Gentuity): 21,347,784,351 yen
- Transfer amount (Spryte): 4,989,574,800 yen
- Transfer date: June 30, 2026
AI要約
Overview of Business Restructuring
Nipro resolved at its Board of Directors meeting on June 26, 2026, to transfer shares of the subsidiary Gentuity and the equity-method affiliate Spryte. This is part of organizational reforms aimed at integrated management of the vascular business, promoting efficiency and focus. The transfer amounts are approximately 21.3 billion yen for Gentuity and approximately 5 billion yen for Spryte, with no expected impact on consolidated performance after the transfers.
Future Outlook and Impact
This share transfer is part of the business restructuring, and its impact on consolidated performance is expected to be limited. Nipro will continue to optimize its business strategies, promoting focus and efficiency in core businesses. The transfer aims to liquidate assets, improve capital efficiency, and reorganize the business portfolio.
Nipro Corporation
Company overview · Stock price · Financial data · All IR
